Target Name: P2RY11
NCBI ID: G5032
Review Report on P2RY11 Target / Biomarker Content of Review Report on P2RY11 Target / Biomarker
P2RY11
Other Name(s): P2Y11 | Purinergic receptor P2Y11 | purinergic receptor P2Y, G-protein coupled, 11 | purinergic receptor P2Y11 | P2Y11_HUMAN | P2Y purinoceptor 11

Understanding The Role of P2RY11 in Pain, Inflammation and Mood

P2RY11, also known as P2Y11, is a protein that is expressed in the brain and plays a crucial role in the regulation of pain, inflammation, and mood. It is a G protein-coupled receptor (GPCR), which means it is a transmembrane protein that is connected to the intracellular signaling pathway. P2RY11 is known for its role in pain signaling and has been targeted by various drugs for its potential as a drug or biomarker.

P2RY11 is a member of the P2Y family of GPCRs, which includes P2Y1, P2Y2, P2Y3, and P2Y4. These proteins are involved in the of extracellular signaling, including pain, inflammation, and mood. The P2Y11 gene regulation is located on chromosome 11 and encodes a 21-kDa protein that is expressed in various tissues throughout the body, including the brain.

P2RY11 is involved in pain signaling by mediating the effects of pain stimuli on the body. When the body experiences pain, P2RY11 is activated, leading to the production of inflammatory cytokines and the release of norepinephrine from the endothelium. These factors contribute to the body's response to pain and can lead to tissue damage and inflammation.

In addition to its role in pain signaling, P2RY11 is also involved in the regulation of inflammation. It has been shown to play a role in the recruitment of immune cells to the site of inflammation and to regulate the production of pro-inflammatory cytokines. This suggests that P2RY11 may have potential as a therapeutic target for the treatment of inflammatory disorders.

P2RY11 has also been shown to be involved in mood regulation. It has been shown to interact with the neurotransmitter dopamine and to play a role in the regulation of dopamine release from the mid-level neurons. This suggests that P2RY11 may be involved in the regulation of mood and that it may have potential as a therapeutic target for the treatment of mood disorders.

Despite the potential for P2RY11 as a drug or biomarker, much research is still needed to fully understand its role in the regulation of pain, inflammation, and mood. In addition, the study of P2RY11 has also been hindered by the lack of resources and the lack of specific antagonists for this protein.

In conclusion, P2RY11 is a protein that plays a crucial role in the regulation of pain, inflammation, and mood. It is a GPCR and its role in these processes is still being fully understood. The potential of P2RY11 as a drug or biomarker is a promising area of 鈥嬧?媟esearch that may have implications for the treatment of various diseases. Further studies are needed to fully understand its role and to develop specific antagonists for this protein.

Protein Name: Purinergic Receptor P2Y11

Functions: Receptor for ATP and ADP coupled to G-proteins that activate both phosphatidylinositol-calcium and adenylyl cyclase second messenger systems. Not activated by UTP or UDP

The "P2RY11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about P2RY11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

P2RY12 | P2RY13 | P2RY14 | P2RY2 | P2RY4 | P2RY6 | P2RY8 | P2X Receptor | P2Y purinoceptor | P3H1 | P3H2 | P3H3 | P3H4 | P3R3URF-PIK3R3 | P4HA1 | P4HA2 | P4HA3 | P4HB | P4HTM | PA28 Complex | PA28gamma Complex | PA2G4 | PA2G4P1 | PA2G4P4 | PAAF1 | PABIR1 | PABIR2 | PABIR3 | PABP-dependent poly(A) nuclease (PAN) complex | PABPC1 | PABPC1L | PABPC1L2A | PABPC1L2B | PABPC1P10 | PABPC1P2 | PABPC1P4 | PABPC1P7 | PABPC3 | PABPC4 | PABPC4-AS1 | PABPC4L | PABPC5 | PABPN1 | PABPN1L | PACC1 | PACERR | PACRG | PACRG-AS2 | PACRGL | PACS1 | PACS2 | PACSIN1 | PACSIN2 | PACSIN3 | PADI1 | PADI2 | PADI3 | PADI4 | PADI6 | PAEP | PAEPP1 | PAF1 | PAF1 complex | PAFAH1B1 | PAFAH1B2 | PAFAH1B2P2 | PAFAH1B3 | PAFAH2 | PAG1 | PAGE1 | PAGE2 | PAGE2B | PAGE3 | PAGE4 | PAGE5 | PAGR1 | PAH | PAICS | PAICSP4 | PAIP1 | PAIP1P1 | PAIP2 | PAIP2B | PAK1 | PAK1IP1 | PAK2 | PAK3 | PAK4 | PAK5 | PAK6 | PAK6-AS1 | PALB2 | PALD1 | PALLD | PALM | PALM2 | PALM2AKAP2 | PALM3 | PALMD | Palmitoyltransferase